药方
医学
系统回顾
协议(科学)
胰十二指肠切除术
胰酶
梅德林
内科学
外科
替代医学
切除术
药理学
病理
政治学
法学
胰腺炎
作者
Sophie Hooke,Kylie Russell,John A. Windsor
标识
DOI:10.37766/inplasy2022.9.0064
摘要
Review question / Objective: The aim of this systematic review is to document the prescribing patterns of PERT in patients following PD to determine the level of compliance with current guidelines/ recommendations.To this end, the proposed systematic review will answer the following questions: 1.What is the prevalence of PERT prescription in patients post-PD? 2. What are the indications for commencement of PERT prescription in patients post-PD? 3. What additional factors are associated with variation in rates of PERT prescription?INPLASY 1 International Platform of Registered Systematic Review and Meta-analysis Protocols INPLASY PROTOCOLPostoperative prevalence of pancreatic enzyme replacement therapy (PERT) prescription in patients postpancreaticoduodenectomy: protocol for a systematic review Hooke, S 1 ; Russell, K 2 ; Windsor, JA 3 .
科研通智能强力驱动
Strongly Powered by AbleSci AI